Overcoming BTK Inhibitor Resistance and Combination Strategies

Source: Advancing the Role of BTK Inhibitors in B-Cell Malignancies: Expert Guidance for Clinical Management
Download Slideset
Download these slides from our ASH 2019 live satellite symposium on overcoming resistance to BTK inhibitors to review the most current clinical data on treating patients with CLL.
Jan A. Burger, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.63 MB
Released: December 6, 2019

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
BeiGene, Ltd.
Loxo Oncology, Inc. a wholly owned subsidiary of Eli Lilly and Company

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings